The Pharmacopoeia of the People's Republic of China (Chinese Pharmacopoeia, or ChP) is China's official collection of standards for drug development, production, sale, utilization, supervision, and control.
ChP is updated by the Chinese Pharmacopoeia Commission every five years. The latest version is the ChP 2020, of which the API & excipient standards are listed in BaiPharm Database.
In China, all drugs shall comply with the ChP standards to obtain marketing authorization. Therefore, ChemLinked BaiPharm Portal holds this webinar to help drug applicants understand and meet the ChP standards.
Related Article: China Issues the 2020 Edition of Chinese Pharmacopoeia